A plea for equitable global access to COVID-19 diagnostics, vaccination and therapy: The NeuroCOVID-19 Task Force of the European Academy of Neurology.

COVID-19 SARS-CoV-2 advocacy disparity equitable global health neurology primary prevention

Journal

European journal of neurology
ISSN: 1468-1331
Titre abrégé: Eur J Neurol
Pays: England
ID NLM: 9506311

Informations de publication

Date de publication:
11 2021
Historique:
received: 05 01 2021
accepted: 13 01 2021
pubmed: 19 1 2021
medline: 27 10 2021
entrez: 18 1 2021
Statut: ppublish

Résumé

Coronavirus disease 2019 (COVID-19), a multi-organ disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continues to challenge health and care systems around the globe. The pandemic has disrupted acute neurology services and routine patient care and has impacted the clinical course in patients with chronic neurological disease. COVID-19 appears to have exposed inequalities of societies and healthcare systems and had a disproportionate impact on already vulnerable communities. The next challenge will be to set up initiatives to stop disparities in all aspects related to COVID-19. From the medical perspective, there is a need to consider inequalities in prevention, treatment and long-term consequences. Some of the issues of direct relevance to neurologists are summarised. With this appraisal, the European Academy of Neurology NeuroCOVID-19 Task Force intends to raise awareness of the potential impact of COVID-19 on inequalities in healthcare and calls for action to prevent disparity at individual, national and supranational levels.

Identifiants

pubmed: 33460486
doi: 10.1111/ene.14741
pmc: PMC8014664
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3849-3855

Informations de copyright

© 2021 The Authors. European Journal of Neurology published by John Wiley & Sons Ltd on behalf of European Academy of Neurology.

Références

Eur J Neurol. 2021 Oct;28(10):3303-3323
pubmed: 33220127
Neurol Sci. 2020 Aug;41(8):1991-1995
pubmed: 32588367
J Community Health. 2021 Aug;46(4):786-793
pubmed: 33258051
Internet Interv. 2020 Sep;21:100330
pubmed: 32542180
J Neurol Sci. 2020 Jul 15;414:116930
pubmed: 32460041
Neurol Sci. 2021 Feb;42(2):399-406
pubmed: 33222101
Front Neurol. 2020 Jul 03;11:737
pubmed: 32719655
Nature. 2021 Jan;589(7840):82-87
pubmed: 33171481
Eur J Neurol. 2021 Jan;28(1):7-14
pubmed: 33058321
J Affect Disord. 2020 Dec 1;277:75-84
pubmed: 32799107
JAMA Intern Med. 2020 Oct 1;180(10):1345-1355
pubmed: 32667669
J Neurol. 2021 Mar;268(3):762-769
pubmed: 32749601
Eur J Neurol. 2021 Oct;28(10):3324-3331
pubmed: 33369818
Neurology. 2020 Jul 14;95(2):77-84
pubmed: 32345728
BMJ Glob Health. 2020 Oct;5(10):
pubmed: 33109636
J Parkinsons Dis. 2020;10(4):1365-1377
pubmed: 32925107
Eur J Neurol. 2021 Oct;28(10):3452-3455
pubmed: 33290619
Stroke. 2021 Jan;52(1):48-56
pubmed: 33280551
Orv Hetil. 2020 Aug;161(34):1395-1399
pubmed: 32804669
Eur J Neurol. 2020 Sep;27(9):e50-e51
pubmed: 32402100
Front Neurol. 2020 Oct 30;11:585944
pubmed: 33193048
Eur Neurol. 2018;80(5-6):289-294
pubmed: 30783053
Eur J Neurol. 2020 Sep;27(9):1712-1726
pubmed: 32503088
Eur J Neurol. 2020 Sep;27(9):1783-1787
pubmed: 32399995
Eur J Neurol. 2020 Dec;27(12):2491-2498
pubmed: 32761981
Eur Econ Rev. 2020 Oct;129:103564
pubmed: 32836323
Public Health Rev. 2017 Sep 8;38:22
pubmed: 29450094
Occup Environ Med. 2020 Dec 9;:
pubmed: 33298533
Neurology. 2020 Jun 16;94(24):1077-1087
pubmed: 32358217
J Eval Clin Pract. 2020 Dec;26(6):1592-1598
pubmed: 32970386
Neurology. 2020 Oct 6;95(14):e2016-e2027
pubmed: 32546654
Bull World Health Organ. 2020 Aug 1;98(8):510-510A
pubmed: 32773892
J Gerontol B Psychol Sci Soc Sci. 2021 Aug 13;76(7):e313-e317
pubmed: 32882025
Psychiatry Res. 2020 Sep;291:113294
pubmed: 32763552
Nature. 2020 Nov 30;:
pubmed: 33257891
Brain Behav Immun. 2020 Aug;88:44-49
pubmed: 32497776
PLoS One. 2020 Oct 28;15(10):e0240960
pubmed: 33112892
Lancet Public Health. 2020 Oct;5(10):e551-e567
pubmed: 33007212
BMJ Open. 2020 Dec 30;10(12):e046620
pubmed: 33380488
Eur J Neurol. 2020 Sep;27(9):1744-1747
pubmed: 32449791
Nat Neurosci. 2021 Feb;24(2):168-175
pubmed: 33257876
J Public Health (Oxf). 2020 Nov 23;42(4):698-703
pubmed: 32776102
Front Public Health. 2021 Jan 08;8:575029
pubmed: 33490013
J Natl Med Assoc. 2020 Dec;112(6):681-687
pubmed: 33276969
Eur J Neurol. 2021 Oct;28(10):3263-3266
pubmed: 33185918
Public Health Res Pract. 2020 Dec 9;30(4):
pubmed: 33294907
J Neurol. 2021 Apr;268(4):1133-1170
pubmed: 32840686
Lancet. 2020 May 9;395(10235):1482-1483
pubmed: 32334651
BMJ. 2020 Aug 19;370:m3021
pubmed: 32816815
Clin Microbiol Infect. 2020 Dec;26(12):1663-1669
pubmed: 32822883
Eur J Neurol. 2021 Jan;28(1):248-258
pubmed: 32853434
Epilepsy Behav. 2021 Feb;115:107573
pubmed: 33268021
Eur J Neurol. 2020 Sep;27(9):1762-1763
pubmed: 32335973
Eur J Neurol. 2021 Oct;28(10):3226-3229
pubmed: 33386655
Nature. 2020 Nov;587(7835):522
pubmed: 33235368
Nat Commun. 2020 Dec 9;11(1):6317
pubmed: 33298944
Eur J Neurol. 2021 Oct;28(10):3437-3442
pubmed: 33368826
Proc Natl Acad Sci U S A. 2020 Dec 22;117(51):32293-32301
pubmed: 33273115
PLoS Med. 2020 Oct 20;17(10):e1003374
pubmed: 33079969
Eur J Neurol. 2020 Sep;27(9):1727-1737
pubmed: 32558002
Eur J Epidemiol. 2020 Dec;35(12):1123-1138
pubmed: 33289900
Glob Health J. 2020 Dec;4(4):113-117
pubmed: 33294250
Stroke. 2020 Sep;51(9):e227-e231
pubmed: 32757751
Int J Environ Res Public Health. 2020 Aug 31;17(17):
pubmed: 32878180
EClinicalMedicine. 2020 Dec;29:100652
pubmed: 33283178
Lancet. 2020 Jun 13;395(10240):1829
pubmed: 32473099
Mov Disord. 2020 Aug;35(8):1287-1292
pubmed: 32449528
Early Hum Dev. 2020 Oct 1;:105214
pubmed: 33041153
Hum Vaccin Immunother. 2021 May 4;17(5):1317-1321
pubmed: 33141000
J Urban Health. 2020 Aug;97(4):461-470
pubmed: 32691212
Front Psychol. 2020 Oct 22;11:573296
pubmed: 33192869
Philos Trans R Soc Lond B Biol Sci. 2014 May 12;369(1645):20130433
pubmed: 24821919
N Engl J Med. 2020 Dec 31;383(27):2603-2615
pubmed: 33301246

Auteurs

Johann Sellner (J)

Department of Neurology, Landesklinikum Mistelbach-Gänserndorf, Mistelbach, Austria.
Department of Neurology, Christian Doppler Medical Center, Paracelsus Medical University, Salzburg, Austria.
Department of Neurology, Klinikum rechts der Isar, Technische Universität München, München, Germany.

Thomas M Jenkins (TM)

Sheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield, UK.
Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.

Tim J von Oertzen (TJ)

Faculty of Medicine, Johannes-Kepler Universität, Linz, Austria.
Department of Neurology 1, Kepler Universitätsklinikum, Linz, Austria.

Claudio L Bassetti (CL)

Department of Neurology, Inselspital, University of Bern, Bern, Switzerland.

Ettore Beghi (E)

Istituto di Ricerche Farmacologiche Mario Negri, IRCCS, Milan, Italy.

Daniel Bereczki (D)

Department of Neurology, Semmelweis University, Budapest, Hungary.

Benedetta Bodini (B)

Department of Neurology, Saint-Antoine Hospital, APHP, Sorbonne University, Paris, France.

Francesco Cavallieri (F)

Neurology Unit, Neuromotor and Rehabilitation Department, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, Modena, Italy.

Giovanni Di Liberto (G)

Department of Clinical Neurosciences, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland.

Raimund Helbok (R)

Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.

Antonella Macerollo (A)

Walton Centre NHS Foundation Trust, Liverpool, UK.
School of Psychology, Faculty of Health and Life Sciences, University of Liverpool, Liverpool, UK.

Luis F Maia (LF)

Department of Neurology, Hospital Santo António, Centro Hospitalar Universitário do Porto, Porto, Portugal.
i3S - Instituto de Investigação e Inovação em Saúde Universidade do Porto, Porto, Portugal.

Celia Oreja-Guevara (C)

Department of Neurology, Hospital Clinico San Carlos, Madrid, Spain.
Departamento de Medicina, Facultad de Medicina, Universidad Complutense de Madrid (UCM, Madrid, Spain.
IdISSC, Madrid, Spain.

Serefnur Özturk (S)

Department of Neurology, Faculty of Medicine, Selcuk University, Konya, Turkey.

Martin Rakusa (M)

Department of Neurology, University Medical Centre Maribor, Maribor, Slovenia.

Antonio Pisani (A)

Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy.
IRCCS Mondino Foundation, Pavia, Italy.

Alberto Priori (A)

Division of Neurology, Department of Neurology, 'Aldo Ravelli' Research Center, University of Milan and ASST Santi Paolo e Carlo, Milan, Italy.

Anna Sauerbier (A)

Department of Neurology, University Hospital Cologne, Cologne, Germany.
King's College Hospital, National Parkinson Foundation International Centre of Excellence, London, UK.

Riccardo Soffietti (R)

Division of Neuro-Oncology, Department of Neuroscience, University of Turin, Turin, Italy.

Pille Taba (P)

Department of Neurology and Neurosurgery, Institute of Clinical Medicine, University of Tartu, Tartu, Estonia.

Marialuisa Zedde (M)

Neurology Unit, Neuromotor and Rehabilitation Department, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, Modena, Italy.

Michael Crean (M)

European Academy of Neurology (EAN) Head Office, Vienna, Austria.

Anja Burlica (A)

European Academy of Neurology (EAN) Head Office, Vienna, Austria.

Alex Twardzik (A)

European Academy of Neurology (EAN) Head Office, Vienna, Austria.

Elena Moro (E)

Division of Neurology, CHU of Grenoble, Grenoble Institute of Neurosciences, Grenoble Alpes University, Grenoble, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH